22 filings
8-K
Coeptis Therapeutics Inc.
28 Oct 22
Submission of Matters to a Vote of Security Holders
9:13am
8-K
Coeptis Therapeutics Inc.
21 Sep 22
Regulation FD Disclosure
12:17pm
8-K
Coeptis Therapeutics Inc.
7 Sep 22
Entry into a Material Definitive Agreement
4:50pm
8-K
Coeptis Therapeutics Inc.
22 Aug 22
Termination of a Material Definitive Agreement
5:24pm
8-K
Coeptis Therapeutics Inc.
6 Jul 22
Regulation FD Disclosure
4:32pm
8-K
3k7ox7 rxnyi
17 May 22
Option agreement comprises three technologies and associated patent portfolios
5:01pm
8-K
svg x3hz3m
19 Apr 22
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
4:51pm
8-K
u546a3in 6o5ac38
12 Apr 22
Entry into a Material Definitive Agreement
5:21pm
8-K
sheln9
5 Apr 22
Departure of Directors or Certain Officers
5:16pm
8-K
uvitv149bdbq6
25 Feb 22
Entry into a Material Definitive Agreement
10:53am
8-K
0s86 80t9sdjp4v4mu68
27 Dec 21
Entry into a Material Definitive Agreement
4:00pm
8-K
uip2m
1 Oct 21
Termination of a Material Definitive Agreement
12:00am
8-K
p8y24c41e76 jx2jfzp
27 Aug 21
Termination of a Material Definitive Agreement
12:00am
8-K
i77 cym8ez0wvwq3r9y
19 Aug 21
Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets
12:53pm
8-K
7ji x36cxt0s
13 Jul 21
New Corporate Name and Updated Stock Ticker Symbol Highlight Company’s Brand Transformation
2:36pm
8-K
f53zwpo32nq51i
11 May 21
Entry into a Material Definitive Agreement
2:20pm
8-K/A
6ow6t1cygdlp42yk8
10 May 21
Completion of Acquisition or Disposition of Assets
7:47am
8-K
gvyd7g9eb
30 Apr 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:19pm
8-K
nd8tbc9
12 Feb 21
Entry into a Material Definitive Agreement
12:51pm
8-K
h8y2mv
4 Jan 21
Entry into a Material Definitive Agreement
3:03pm